Hiscox updates banking facilities and capital headroom, shares supported by robust Solvency II ratio

By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-26, 09:58.

Hiscox Ltd (BMG4593F1389) has refreshed its core corporate banking arrangements in 2025, underpinning liquidity and capital flexibility alongside a Solvency II coverage ratio above 200 percent at year-end 2024, according to its latest annual report and AGM documentation.Hiscox 2024 annual report The specialist insurer’s shares trade on the London Stock Exchange under ticker HSX, alongside peers such as Beazley and Lancashire in the UK non-life segment.

What Hiscox disclosed on capital

In its 2024 annual report published in March 2025, Hiscox reported a Solvency II coverage ratio of 203 percent, compared with 212 percent a year earlier, citing strong underwriting profits and active capital deployment including growth in reinsurance and big-ticket lines.Hiscox 2024 annual report The group highlighted that this ratio remains comfortably within its 155-195 percent risk appetite range, giving headroom for growth and shareholder distributions.

The company also flagged the renewal and extension of its syndicated revolving credit facility in 2024, which now provides committed bank lines through at least 2028, supplementing its tier 2 subordinated debt and senior notes as part of its capital stack.Hiscox 2024 annual report Management described the facility as a backstop for liquidity needs in extreme loss scenarios, rather than a primary funding source.

Analyst views and London listing

On the research side, data compiled by Bitget and other aggregators shows that recent analyst recommendations from houses such as Jefferies and Barclays skew towards Buy or Hold on Hiscox after the strong 2023 and 2024 results, with focus on improving underwriting margins and better catastrophe discipline.Bitget overview on Hiscox HSX The stock trades on the London Stock Exchange’s Main Market under the HSX ticker, with sector peers including Beazley and Lancashire also active in specialty and reinsurance lines.

Consensus data from several market platforms points to a majority of analysts rating the Hiscox stock at Buy or Hold, with only a minority on Sell, reflecting confidence in the group’s balance sheet strength and its diversified specialty portfolio across London Market, Re & ILS and Retail segments.Bitget overview on Hiscox HSX Average price targets compiled by these platforms stand above the current share price in mid-2025, but with varying upside estimates.

How Hiscox makes its money

Hiscox generates most of its revenue from specialty insurance and reinsurance, including lines such as property, cyber, professional indemnity, fine art and terrorism cover for corporate, high-net-worth and retail clients across the UK, Europe, the US and international markets.Hiscox 2024 annual report The group reports through segments such as Hiscox Retail, Hiscox London Market and Hiscox Re & ILS, combining underwriting income and investment returns to generate profit.

Where the stock trades today

The Hiscox shares (BMG4593F1389) most recently traded on the London Stock Exchange at around 12.00 pounds, giving the group a market capitalization in the mid-single-digit billion pound range, based on data from LSE price feeds and market platforms as of late June 2025.

This article is for informational purposes only and does not constitute investment advice, an offer, or a solicitation to buy or sell any financial instrument. Historical performance is not a reliable indicator of future results. Investors should conduct their own research and consider their individual financial situation before making investment decisions.